Fundz Deep Dive
Everything you need to win Albert Bourla — in one platform.
Who to reach, what to say, and why now on Albert Bourla — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Albert Bourla — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Pfizer Initiates Search for Successor To Dr. Mikael Dolsten As Chief Scientific Officer
PUBLIC · PFEJul 09, 2024•almost 2 years ago
Position
Chief Executive Officer
Company
Pfizer
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmapharmaceuticalsDescription
Pfizer Inc. has announced the initiation of the process to identify a successor for Dr. Mikael Dolsten, who currently serves as the Chief Scientific Officer and President of Pfizer Research & Development
Related People
Suggested for you
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months